Relaxo Footwears Intrinsic Value
Relaxo Footwears intrinsic value. Relaxo Footwears (RELAXO) median intrinsic value is ₹563.90 from 10 valuation models (range ₹85–₹705), vs current price ₹281.95 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Read RELAXO dividend track record for the complete payout history and dividend yield track record.
RELAXO Valuation Methods Summary — DCF, Graham Number & P/E
Relaxo Footwears intrinsic value across 10 models vs current price ₹281.95 — upside/downside and value range per method. For current market price and key ratios, visit RELAXO share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹187.50 | ₹150.00 - ₹225.00 | -33.5% | EPS: ₹7.50, Sector P/E: 25x |
| Book Value Method | asset | ₹704.88 | ₹634.39 - ₹775.37 | +150.0% | Book Value/Share: ₹882.40, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹563.90 | ₹507.51 - ₹620.29 | +100.0% | Revenue/Share: ₹1120.40, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹563.90 | ₹507.51 - ₹620.29 | +100.0% | EBITDA: ₹431.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹704.88 | ₹563.90 - ₹845.86 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹84.58 | ₹76.12 - ₹93.04 | -70.0% | EPS Growth: 4.8%, Fair P/E: 3.9x |
| Growth Adjusted P/E | growth | ₹139.05 | ₹125.15 - ₹152.96 | -50.7% | Revenue Growth: 6.0%, Adj P/E: 18.5x |
| ROE Based Valuation | profitability | ₹563.90 | ₹507.51 - ₹620.29 | +100.0% | ROE: 8.4%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹385.88 | ₹347.29 - ₹424.47 | +36.9% | EPS: ₹7.50, BVPS: ₹882.40 |
| Dividend Yield Method | dividend | ₹116.67 | ₹105.00 - ₹128.34 | -58.6% | DPS: ₹3.50, Target Yield: 3.0% |
RELAXO Intrinsic Value vs Market Price — All Valuation Models
Relaxo Footwears fair value range ₹85–₹705 vs current market price ₹281.95 across 10 valuation models. Compare with Relaxo Footwears value estimation to assess whether the stock is under or overvalued.
RELAXO Intrinsic Value Analysis — Undervalued or Overvalued?
Relaxo Footwears median intrinsic value ₹563.90, current price ₹281.95 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of RELAXO?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Relaxo Footwears (RELAXO) is ₹563.90 (median value). With the current market price of ₹281.95, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹84.58 to ₹704.88, indicating ₹84.58 - ₹704.88.
Is RELAXO undervalued or overvalued?
Based on our multi-method analysis, Relaxo Footwears (RELAXO) appears to be trading below calculated value by approximately 100.0%.
RELAXO Financial Health — Key Ratios vs Industry Benchmarks
Relaxo Footwears financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 5.19 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 8.4% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 14.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.95x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
RELAXO Cash Flow Quality — Operating & Free Cash Flow
Relaxo Footwears operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹348 Cr | ₹245 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹406 Cr | ₹275 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹235 Cr | ₹186 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹400 Cr | ₹271 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹56 Cr | ₹56 Cr | Positive Free Cash Flow | 8/10 |